Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
OPERATING ACTIVITIES:
Consolidated net (loss) income	$ (433,278)	$ 26,603
Adjustments to reconcile consolidated net (loss) income to Net cash used in operating activities:
Depreciation and amortization	74,588	66,819
Share-based compensation	7,595	15,331
Amortization of debt issuance costs and premium / discount	9,952	9,776
Provision for bad debts	775	744
Selling, general and administrative expenses paid in shares of ordinary shares	86	69
Deferred income taxes	(186,222)	8,644
Net loss on disposal of property, plant and equipment	875	213
Change in fair value of acquisition-related contingent consideration	12	40
Loss on extinguishment of debt	9,596	11,312
Asset impairment charges	0	1,100
Gain on sale of business	(1,545)	0
Changes in assets and liabilities which (used) provided cash:
Accounts receivable	43,889	(21,989)
Inventories	(6,643)	(27,153)
Prepaid and other assets	12,636	1,476
Accounts payable	(59,916)	(136,323)
Accrued expenses	298,229	(94,160)
Other liabilities	37,489	86,922
Income taxes payable/receivable	(55,061)	(8,171)
Net cash used in operating activities	(246,943)	(58,747)
INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(20,837)	(23,956)
Proceeds from sale of property, plant and equipment	19	311
Acquisitions, net of cash acquired	(113,464)	(3,645)
Proceeds from sale of marketable securities	15,167	0
Patent acquisition costs and license fees	0	(10,000)
Proceeds from sale of business, net	55,271	0
Settlement escrow	3,148	0
Decrease in restricted cash and cash equivalents	702,495	0
Net cash provided by (used in) investing activities	641,799	(37,290)
FINANCING ACTIVITIES:
Capital lease obligations repayments	(25)	(89)
Direct financing arrangement repayments	(910)	(857)
Proceeds from issuance of Term Loans	1,525,000	0
Proceeds from other indebtedness	0	223
Principal payments on Term Loans	(1,396,019)	(100,000)
Payment on AMS Convertible Notes	(5)	0
Principal payments on other indebtedness	(2,194)	0
Deferred financing fees	(38,435)	(7,251)
Payment for contingent consideration	0	(5,000)
Tax benefits of share awards	23,861	1,998
Payments of tax withholding for restricted shares	(21,475)	0
Exercise of options	21,593	12,826
Payments related to the issuance of common stock	(4,800)	0
Issuance of ordinary shares related to the employee stock purchase plan	1,178	1,557
Cash distributions to noncontrolling interests	(5,285)	(12,832)
Cash buy-out of noncontrolling interests, net of cash contributions	(82)	(1,525)
Net cash provided by (used in) financing activities	102,402	(110,950)
Effect of foreign exchange rate	12	(412)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	497,270	(207,399)
LESS: NET DECREASE IN CASH AND CASH EQUIVALENTS OF DISCONTINUED OPERATIONS	(17,413)	(4,722)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS OF CONTINUING OPERATIONS	514,683	(202,677)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	526,597	529,689
CASH AND CASH EQUIVALENTS, END OF PERIOD	1,041,280	327,012
SUPPLEMENTAL INFORMATION:
Cash paid for interest	40,719	40,714
Cash paid for income taxes	14,235	993
SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Purchases of property, plant and equipment financed by capital leases	4	0
Acquisition financed by ordinary shares	2,844,279	0
Accrual for purchases of property, plant and equipment	$ 5,589	$ 4,083